zd 7288 has been researched along with 1-ethyl-2-benzimidazolinone in 1 studies
Studies (zd 7288) | Trials (zd 7288) | Recent Studies (post-2010) (zd 7288) | Studies (1-ethyl-2-benzimidazolinone) | Trials (1-ethyl-2-benzimidazolinone) | Recent Studies (post-2010) (1-ethyl-2-benzimidazolinone) |
---|---|---|---|---|---|
382 | 0 | 137 | 126 | 0 | 37 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karakossian, MH; Maiz, J; Otis, TS; Pakaprot, N; Robleto, K; Thompson, RF | 1 |
1 other study(ies) available for zd 7288 and 1-ethyl-2-benzimidazolinone
Article | Year |
---|---|
Prolonging the postcomplex spike pause speeds eyeblink conditioning.
Topics: Analysis of Variance; Animals; Benzimidazoles; Blinking; Calcium Channel Agonists; Cardiovascular Agents; Cerebellar Nuclei; Cerebellum; Conditioning, Eyelid; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Learning; Mice; Nerve Fibers; Picrotoxin; Purkinje Cells; Pyrimidines; Quinoxalines; Rats; Rats, Sprague-Dawley; Time Factors | 2012 |